Skip to main content
 This program is not active.
On Demand

What We Know About Improving Neurodevelopmental Outcomes During Pregnancy


Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   4
State Associations:
OPSC - California
Faculty:
Robert Hendren, DO
Duration:
54 Minutes
Expiration:
Never expires.


Description

Current understanding of the etiology of autism is based on the interaction of multiple genes with each other and with environmental factors, leading to a neurodevelopmental process that results in the expression of neurodevelopmental disorders (NDDs) in the child. This suggests that it might be possible to strengthen resilience to environmental stressors during the perinatal period to improve outcomes and possibly prevent the development of NDDs.

Learning Objectives:
1. Present a model for gene-environment, epigenetic influences on neurodevelopment during pregnancy
2. Describe perinatal risk factors for the development of Neurodevelopmental Disorder;
3. Describe potential interventions with the strongest evidence to boost neurodevelopmental resilience that can be utilized in the perinatal period.

Disclosures: Curemark, Roche, Shire, Sunovian (Grant/Research Support); BioMarin, Axial Therapeutics, Janssen (Consultant)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Osteopathic Physicians and Surgeons of California (OPSC) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. 

Grievance Policy: OPSC strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to OPSC, by calling the OPSC Office at 916-822-5246 or by email to opsc@opsc.org

Handouts

Faculty

Robert Hendren, DO Related Seminars and Products


Robert L. Hendren, D.O., is Professor of Psychiatry and Behavioral Science; Division of Child and Adolescent Psychiatry; Co-Director of the UCSF Dyslexia Center; and Director, Program for Research On Neurodevelopmental and Translational Outcomes (PRONTO). Dr. Hendren is Past President of the American Academy of Child and Adolescent Psychiatry (2007-2009). He has published well over 100 scientific papers and 5 books and has been listed in “The Best Doctors in America”, each year since it was first published in 1996.
 
Dr. Hendren earned his DO degree from Kirksville College of Osteopathic Medicine; did a rotating internship at Doctor’s Columbus; took his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders).
His current areas of research and publication interests are translational interventional outcomes research including clinical pharmacology, nutraceutical and nutritional trials using biomarkers (metabolomics, measures of inflammation, oxidative stress, immune function, pharmacogenomics and neuroimaging) to enhance resilience in neurodevelopmental disorders. He is currently applying a targeted outcomes research approach in collaborative projects with the Oak Hill School for youth with severe autism and neurodevelopmental spectrum disorders in San Anselmo, CA, Meristem Academy in Sacramento, and the Charles Armstrong School for youth with dyslexia in Belmont, CA.


Reviews

5
4
3
2
1

Overall:      3.8

Total Reviews: 4